James J Hsieh

19PUBLICATIONS
91CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical infection agents (incl. prions)Cancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Dec 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.

Yige Wu, Siqi Chen, Xiaolu Yang

|May 17, 2023
Author Correction: Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.

Yige Wu, Nadezhda V Terekhanova, Wagma Caravan

|Mar 27, 2023
Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma.

Yige Wu, Nadezhda V Terekhanova, Wagma Caravan

|May 16, 2022
Telaglenastat plus Everolimus in Advanced Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled, Phase II ENTRATA Trial.

Chung-Han Lee, Robert Motzer, Hamid Emamekhoo

|Feb 04, 2022
SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes.

Yuchen Xie, Merve Sahin, Sonali Sinha

|Mar 27, 2021
Single-cell Spatial Proteomic Revelations on the Multiparametric MRI Heterogeneity of Clinically Significant Prostate Cancer.

Russell K Pachynski, Eric H Kim, Natalia Miheecheva

Pageof 4

Frequent Collaborators

6 joint publications

Yingbei Chen

4 joint publications

Yiyu Dong

3 joint publications

Feng Chen

3 joint publications

Xiaolu Yang